Rectal artesunate for pre-referral treatment of severe malaria


Cover of the publication

Publication details

Number of pages: 8
Publication date: October 2017 (updated October 2018)
Languages: English, French
WHO reference number: WHO/HTM/GMP/2017.19


─  Read the document in French


Severe malaria is a medical emergency requiring prompt and effective antimalarial treatment. In areas where comprehensive treatment cannot be provided, several pre-referral treatment options can be used, depending on the age of the patient and the availability of medicines.

Rectal artesunate is recommended for children under six years of age living in remote areas. Children with severe febrile illness and suspected severe malaria can be treated without delay, pending immediate transfer to a higher-level facility where comprehensive care can be given.

This information note aims to prepare countries for the large-scale deployment and correct use of this life-saving commodity.

Related links